CryoLife Company Profile (NYSE:CRY)

About CryoLife (NYSE:CRY)

CryoLife logoCryoLife, Inc. (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc. valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix. PhotoFix is a pericardial patch stabilized using a dye-mediated photo-fixation process that requires no glutaraldehyde. The Preservation Services segment includes external services, such as preservation of cardiac and vascular tissues. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch, both of which are processed using CryoLife's SynerGraft technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution - NEC
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:CRY
  • CUSIP: 22890310
  • Web:
  • Market Cap: $635.47 million
  • Outstanding Shares: 33,446,000
Average Prices:
  • 50 Day Moving Avg: $19.18
  • 200 Day Moving Avg: $17.98
  • 52 Week Range: $14.02 - $20.30
  • Trailing P/E Ratio: 57.73
  • Foreward P/E Ratio: 46.46
  • P/E Growth: 1.47
Sales & Book Value:
  • Annual Revenue: $183.16 million
  • Price / Sales: 3.48
  • Book Value: $6.56 per share
  • Price / Book: 2.90
  • EBIDTA: $23.56 million
  • Net Margins: 6.16%
  • Return on Equity: 7.41%
  • Return on Assets: 4.95%
  • Debt-to-Equity Ratio: 0.30%
  • Current Ratio: 5.91%
  • Quick Ratio: 4.88%
  • Average Volume: 112,453 shs.
  • Beta: 0.97
  • Short Ratio: 4.16

Frequently Asked Questions for CryoLife (NYSE:CRY)

What is CryoLife's stock symbol?

CryoLife trades on the New York Stock Exchange (NYSE) under the ticker symbol "CRY."

How were CryoLife's earnings last quarter?

CryoLife, Inc. (NYSE:CRY) announced its quarterly earnings results on Monday, July, 24th. The company reported $0.12 EPS for the quarter, beating the Zacks' consensus estimate of $0.10 by $0.02. The company had revenue of $47.80 million for the quarter, compared to analysts' expectations of $47.02 million. CryoLife had a net margin of 6.16% and a return on equity of 7.41%. CryoLife's revenue was up 1.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.13 EPS. View CryoLife's Earnings History.

When will CryoLife make its next earnings announcement?

CryoLife is scheduled to release their next quarterly earnings announcement on Tuesday, October, 24th 2017. View Earnings Estimates for CryoLife.

What guidance has CryoLife issued on next quarter's earnings?

CryoLife issued an update on its FY17 earnings guidance on Monday, July, 24th. The company provided earnings per share guidance of $40-0.43 for the period, compared to the Thomson Reuters consensus estimate of $0.43. The company issued revenue guidance of $188-192 million, compared to the consensus revenue estimate of $189.31 million.

Where is CryoLife's stock going? Where will CryoLife's stock price be in 2017?

3 equities research analysts have issued 1-year price objectives for CryoLife's shares. Their forecasts range from $20.00 to $23.50. On average, they expect CryoLife's stock price to reach $22.33 in the next year. View Analyst Ratings for CryoLife.

Who are some of CryoLife's key competitors?

Who are CryoLife's key executives?

CryoLife's management team includes the folowing people:

  • James Patrick Mackin, Chairman of the Board, President, Chief Executive Officer
  • D. Ashley Lee CPA, Chief Financial Officer, Chief Operating Officer, Executive Vice President
  • James M McDermid, Chief Human Resource Officer
  • John Davis, Senior Vice President - Global Sales and Marketing
  • William Matthews, Senior Vice President - Operations, Quality, and Regulatory
  • Amy D. Horton CPA, Chief Accounting Officer
  • Jean F. Holloway, Chief Compliance Officer, Vice President, General Counsel, Secretary
  • Scott B. Capps, Vice President - Clinical Research
  • David C. Gale Ph.D., Vice President - Research & Development
  • James Bullock, Director

Who owns CryoLife stock?

CryoLife's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Capital Research Global Investors (8.54%), Dimensional Fund Advisors LP (5.86%), Vanguard Group Inc. (4.96%), Macquarie Group Ltd. (4.15%), Northern Trust Corp (3.50%) and State Street Corp (2.27%). Company insiders that own CryoLife stock include Amy Horton, C Elkins Ronald, David Ashley Lee, James Benson, James P Mackin, Ronald D Mccall and Scott B Capps. View Institutional Ownership Trends for CryoLife.

Who sold CryoLife stock? Who is selling CryoLife stock?

CryoLife's stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, Goldman Sachs Group Inc., Royal Bank of Canada, Alliancebernstein L.P., Candriam Luxembourg S.C.A., TIAA CREF Investment Management LLC, California State Teachers Retirement System and Public Sector Pension investment Board. Company insiders that have sold CryoLife stock in the last year include Amy Horton and Scott B Capps. View Insider Buying and Selling for CryoLife.

Who bought CryoLife stock? Who is buying CryoLife stock?

CryoLife's stock was bought by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Macquarie Group Ltd., Dimensional Fund Advisors LP, Vanguard Group Inc., Thomson Horstmann & Bryant Inc., Northern Trust Corp, Marshall Wace North America L.P. and Parametric Portfolio Associates LLC. View Insider Buying and Selling for CryoLife.

How do I buy CryoLife stock?

Shares of CryoLife can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CryoLife's stock price today?

One share of CryoLife stock can currently be purchased for approximately $19.05.

MarketBeat Community Rating for CryoLife (NYSE CRY)
Community Ranking:  3.0 out of 5 (  )
Outperform Votes:  111 (Vote Outperform)
Underperform Votes:  74 (Vote Underperform)
Total Votes:  185
MarketBeat's community ratings are surveys of what our community members think about CryoLife and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for CryoLife (NYSE:CRY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $22.33 (17.24% upside)

Analysts' Ratings History for CryoLife (NYSE:CRY)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/28/2017Northland SecuritiesReiterated RatingBuy$23.50LowView Rating Details
2/17/2017Ladenburg Thalmann Financial ServicesUpgradeNeutral -> Buy$20.00N/AView Rating Details
1/23/2017Canaccord GenuityReiterated RatingBuy$23.50N/AView Rating Details
7/27/2016Piper Jaffray CompaniesReiterated RatingOverweight$16.00N/AView Rating Details
6/15/2016Lake Street CapitalInitiated CoverageBuy$15.00N/AView Rating Details
(Data available from 8/19/2015 forward)


Earnings History for CryoLife (NYSE:CRY)
Earnings by Quarter for CryoLife (NYSE:CRY)
Earnings History by Quarter for CryoLife (NYSE CRY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017$0.11N/AView Earnings Details
7/24/2017Q2 2017$0.10$0.12$47.02 million$47.80 millionViewN/AView Earnings Details
4/26/2017Q1 2017$0.04$0.09$44.64 million$45.10 millionViewN/AView Earnings Details
2/15/2017Q416$0.09$0.12$46.92 million$45.00 millionViewListenView Earnings Details
10/26/2016Q316$0.05$0.13$44.90 million$45.30 millionViewListenView Earnings Details
7/25/2016Q216$0.02$0.13$35.50 million$47.10 millionViewListenView Earnings Details
4/27/2016Q116$0.02$0.10$40.50 million$43.00 millionViewListenView Earnings Details
2/15/2016Q415$0.05$0.13$40.04 million$39.80 millionViewListenView Earnings Details
10/27/2015Q315$0.01$0.10$38.17 million$36.70 millionViewListenView Earnings Details
7/28/2015Q215$0.03$35.57 million$35.50 millionViewListenView Earnings Details
4/28/2015Q115$0.01($0.01)$36.55 million$33.80 millionViewListenView Earnings Details
2/17/2015Q414$0.05$0.04$37.42 million$37.20 millionViewListenView Earnings Details
10/28/2014Q314$0.05$0.08$37.70 million$37.10 millionViewListenView Earnings Details
7/24/2014Q214$0.05$0.08$35.72 million$34.69 millionViewListenView Earnings Details
4/29/2014Q114$0.07$0.04$37.30 million$35.73 millionViewListenView Earnings Details
2/20/2014Q413$0.35$0.31$34.90 million$35.50 millionViewListenView Earnings Details
10/29/2013Q313$0.05$0.12$35.51 million$36.30 millionViewListenView Earnings Details
7/25/2013Q2 2013$0.07$0.08$35.63 million$33.50 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.07$0.08$35.04 million$35.50 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.05$0.08$33.58 million$32.80 millionViewListenView Earnings Details
10/30/2012Q312$0.04$0.08$32.45 million$33.40 millionViewN/AView Earnings Details
7/31/2012$0.05$0.10ViewN/AView Earnings Details
4/26/2012$0.05$0.04ViewN/AView Earnings Details
2/16/2012$0.06$0.07ViewN/AView Earnings Details
10/27/2011$0.08$0.07ViewN/AView Earnings Details
7/28/2011$0.06$0.12ViewN/AView Earnings Details
4/28/2011$0.08$0.09ViewN/AView Earnings Details
2/17/2011$0.07$0.08ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CryoLife (NYSE:CRY)
2017 EPS Consensus Estimate: $0.28
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.04$0.06$0.05
Q2 20172$0.07$0.07$0.07
Q3 20172$0.06$0.07$0.07
Q4 20172$0.09$0.10$0.10
Q1 20181$0.07$0.07$0.07
Q2 20181$0.10$0.10$0.10
(Data provided by Zacks Investment Research)


Current Dividend Information for CryoLife (NYSE:CRY)
Most Recent Dividend:12/18/2015
Dividend Yield:0.00%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:0.00% (Trailing 12 Months of Earnings)
0.00% (Based on This Year's Estimates)
0.00% (Based on Next Year's Estimates)
Track Record:4 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for CryoLife (NYSE:CRY)

Dividend History by Quarter for CryoLife (NYSE CRY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for CryoLife (NYSE:CRY)
Insider Ownership Percentage: 6.00%
Institutional Ownership Percentage: 69.22%
Insider Trades by Quarter for CryoLife (NYSE:CRY)
Institutional Ownership by Quarter for CryoLife (NYSE:CRY)
Insider Trades by Quarter for CryoLife (NYSE:CRY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/27/2017Amy HortonVPSell9,577$20.00$191,540.00View SEC Filing  
2/22/2017Scott B CappsVPSell11,083$16.40$181,761.20View SEC Filing  
7/26/2016C Elkins RonaldDirectorSell2,000$14.00$28,000.00View SEC Filing  
6/1/2016Ronald D MccallDirectorSell10,000$11.56$115,600.00View SEC Filing  
5/10/2016James BensonDirectorSell5,000$12.22$61,100.00View SEC Filing  
4/15/2016C Elkins RonaldDirectorSell1,000$12.00$12,000.00View SEC Filing  
3/7/2016C Elkins RonaldDirectorSell2,000$11.18$22,360.00View SEC Filing  
3/4/2016James P MackinCEOBuy10,000$10.91$109,100.00View SEC Filing  
2/19/2016Scott B CappsVPSell15,000$10.30$154,500.00View SEC Filing  
2/18/2016David Ashley LeeCFOSell8,000$10.13$81,040.00View SEC Filing  
12/28/2015David Ashley LeeCFOSell700$11.00$7,700.00View SEC Filing  
11/30/2015David Ashley LeeCFOSell11,800$11.03$130,154.00View SEC Filing  
9/15/2015James BensonDirectorSell5,839$9.65$56,346.35View SEC Filing  
9/11/2015James BensonDirectorSell3,359$9.65$32,414.35View SEC Filing  
2/19/2015Steven G AndersonChairmanSell30,000$10.93$327,900.00View SEC Filing  
12/9/2014Bruce G AndersonVPSell3,900$10.29$40,131.00View SEC Filing  
11/25/2014Bruce G AndersonVPSell20,211$10.11$204,333.21View SEC Filing  
11/5/2014C Elkins RonaldDirectorSell4,000$10.08$40,320.00View SEC Filing  
11/3/2014James BensonDirectorSell10,000$10.22$102,200.00View SEC Filing  
9/8/2014Bruce G AndersonVPSell10,000$10.05$100,500.00View SEC Filing  
9/2/2014Steven G AndersonChairmanSell20,000$10.08$201,600.00View SEC Filing  
8/25/2014Bruce G AndersonVPSell5,000$10.05$50,250.00View SEC Filing  
8/18/2014Bruce G AndersonVPSell10,000$10.52$105,200.00View SEC Filing  
8/14/2014David Ashley LeeCFOSell10,000$10.51$105,100.00View SEC Filing  
8/13/2014David Ashley LeeCFOSell9,881$10.51$103,849.31View SEC Filing  
8/13/2014Jeffrey W BurrisVPSell11,000$10.50$115,500.00View SEC Filing  
7/29/2014C Elkins RonaldDirectorSell2,500$9.67$24,175.00View SEC Filing  
7/28/2014Bruce G AndersonVPSell5,000$9.48$47,400.00View SEC Filing  
7/28/2014Steven G AndersonCEOSell19,477$9.52$185,421.04View SEC Filing  
6/9/2014Amy HortonCAOSell2,500$9.26$23,150.00View SEC Filing  
5/16/2014David FronkVPSell8,952$8.61$77,076.72View SEC Filing  
5/13/2014Steven AndersonCEOSell30,523$9.00$274,707.00View SEC Filing  
5/6/2014Bruce AndersonVPSell16,870$8.83$148,962.10View SEC Filing  
11/26/2013Jeffrey BurrisVPSell5,000$10.50$52,500.00View SEC Filing  
11/11/2013Jeffrey BurrisVPSell5,000$10.00$50,000.00View SEC Filing  
11/7/2013Steven AndersonCEOSell100,000$9.38$938,000.00View SEC Filing  
10/29/2013C Elkins RonaldDirectorSell2,000$9.00$18,000.00View SEC Filing  
10/29/2013Jeffrey W BurrisVPSell5,000$9.00$45,000.00View SEC Filing  
8/27/2013Bruce AndersonVPSell4,500$6.33$28,485.00View SEC Filing  
8/8/2013Amy HortonCAOSell2,500$7.07$17,675.00View SEC Filing  
8/1/2013Ronald D MccallDirectorSell6,000$7.10$42,600.00View SEC Filing  
6/6/2013Ronald D MccallDirectorSell4,000$6.15$24,600.00View SEC Filing  
5/31/2013C Elkins RonaldDirectorSell2,250$6.15$13,837.50View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for CryoLife (NYSE:CRY)
Latest Headlines for CryoLife (NYSE:CRY)
DateHeadline logoZacks Investment Research Upgrades CryoLife, Inc. (NYSE:CRY) to Hold - August 14 at 7:56 PM logoETFs with exposure to CryoLife, Inc. : August 14, 2017 - August 14 at 5:56 PM logoETFs with exposure to CryoLife, Inc. : August 4, 2017 - August 4 at 12:00 AM logoZacks Investment Research Lowers CryoLife, Inc. (CRY) to Sell - August 2 at 9:34 PM logoCryoLife to Present at 37th Annual Canaccord Genuity Growth Conference - August 2 at 6:23 PM logoCryoLife, Inc. to Post FY2017 Earnings of $0.31 Per Share, First Analysis Forecasts (NYSE:CRY) - August 2 at 10:38 AM logoEcolab (ECL) Beats Earnings and Revenue Estimates in Q2 - August 1 at 6:16 PM logoBrokers Offer Predictions for CryoLife, Inc.'s Q3 2017 Earnings (NYSE:CRY) - August 1 at 8:02 AM logoCryoLife, Inc. breached its 50 day moving average in a Bearish Manner : CRY-US : July 28, 2017 - July 29 at 4:52 PM logoCryoLife, Inc. :CRY-US: Earnings Analysis: Q2, 2017 By the Numbers : July 26, 2017 - July 26 at 6:07 PM logoEdited Transcript of CRY earnings conference call or presentation 25-Jul-17 12:00pm GMT - July 25 at 10:40 PM logoInvestor Network: CryoLife, Inc. to Host Earnings Call - July 25 at 5:34 PM logoCryoLife posts 2Q profit - July 24 at 10:17 PM logoCryoLife, Inc. (NYSE:CRY) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS - July 24 at 9:14 PM logoCryoLife, Inc. (NYSE:CRY) Receives Average Recommendation of "Buy" from Analysts - July 24 at 6:50 PM logoCryoLife, Inc. (CRY) Updates FY17 Earnings Guidance - July 24 at 5:25 PM logoCryoLife Reports Second Quarter 2017 Financial Results - July 24 at 5:13 PM logoStryker Poised on Solid Product Portfolio and Acquisitions - July 18 at 7:04 PM logoCryoLife, Inc. (NYSE:CRY) Scheduled to Post Earnings on Monday - July 17 at 8:52 AM logoMcKesson (MCK) Poised on Improving Generic and Brand Market - July 13 at 6:47 PM logoFresenius Medical (FMS) Well Poised on Growth Strategy 2020 - July 12 at 6:15 PM logoMasimo (MASI) Rainbow Super DCI-mini Sensor Now CE Marked - July 12 at 6:15 PM logoAmerisourceBergen's PharMEDium Slows Down, Competition Rife - July 11 at 11:41 PM logoHeart Valve Devices Market 13.35% CAGR by 2021 With TAVR and TMVR Says a Research Report Available at ReportsnReports - July 11 at 11:41 PM logoAmerisourceBergen's PharMEDium Slows Down, Competition Rife - July 11 at 6:39 PM logoCryoLife Announces Release Date and Teleconference Call Details for 2017 Second Quarter Financial Results - July 10 at 5:31 PM logoAmy Horton Sells 9,577 Shares of CryoLife, Inc. (CRY) Stock - June 29 at 10:32 AM logoCryoLife Hits a 52-Week High: What's Driving the Stock? - June 28 at 5:28 PM logoVarian Rides on Oncology and Proton Therapy Businesses - June 28 at 5:28 PM logoCryoLife Hits a 52-Week High: What's Driving the Stock? - June 28 at 5:28 PM logoQuintiles' (Q) OCE Software to Simplify Commercial Functions - June 27 at 4:49 PM logoETFs with exposure to CryoLife, Inc. : June 26, 2017 - June 26 at 5:20 PM logoLuminex (LMNX) Banks on Portfolio Strength, View Impressive - June 22 at 10:41 AM logoCryolife Inc (CRY) Upgraded to "Buy" at Zacks Investment Research - June 8 at 7:12 PM logoCryolife Inc (CRY) Forecasted to Earn Q1 2018 Earnings of $0.07 Per Share - June 7 at 9:14 AM logoETFs with exposure to CryoLife, Inc. : June 6, 2017 - June 6 at 4:44 PM logoFirst Analysis Weighs in on Cryolife Inc's Q2 2017 Earnings (CRY) - June 6 at 7:08 AM logoProsthetic Heart Valve/Artificial Heart Valve Market Worth 8.86 Billion USD by 2022 - June 5 at 12:02 PM logoCryolife Inc (CRY) Receives Consensus Rating of "Buy" from Brokerages - May 29 at 11:08 PM logoETFs with exposure to CryoLife, Inc. : May 22, 2017 - May 22 at 4:20 PM logoC. R. Bard, Inc. (BCR) - May 14 at 4:36 PM logoETFs with exposure to CryoLife, Inc. : May 8, 2017 - May 8 at 9:23 PM logoCryolife (CRY) Receives Daily News Impact Rating of 0.03 - May 3 at 3:05 PM logoCryolife Inc (CRY) Given Average Recommendation of "Buy" by Brokerages - May 3 at 12:34 AM logoCryoLife, Inc. :CRY-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017 - May 1 at 4:27 PM logoCryolife (CRY) Receives News Sentiment Score of 0.32 - April 29 at 9:35 PM logoCryoLife, Inc. – Value Analysis (NYSE:CRY) : April 28, 2017 - April 28 at 5:29 PM logoCryolife Inc (CRY) Earns "Buy" Rating from Northland Securities - April 28 at 2:58 PM logoCryoLife, Inc. breached its 50 day moving average in a Bullish Manner : CRY-US : April 27, 2017 - April 28 at 3:06 AM logoEdited Transcript of CRY earnings conference call or presentation 27-Apr-17 12:00pm GMT - April 28 at 3:06 AM



CryoLife (CRY) Chart for Saturday, August, 19, 2017

This page was last updated on 8/19/2017 by Staff